MG Client Spotlight – Valuation Plays a Role in Supporting Big Scientific Strides – Medical help on the way thanks to the powerful gene editing technology CRISPR

MG Valuation Blog, Featured News, News

http://www.mgvaluation.com/wp-content/uploads/2019/03/MG-Client-Spotlight_CRISPR-1.pdf This technology involves the clinical potential of altering genes in organisms to delete undesirable traits, and add new ones, and is being explored with new technologies. Included is Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas-9. CRISPR is a genome-editing tool that can selectively delete, modify or correct a disease-causing abnormality in a specific DNA segment, and refers to an occurrence in the genome of certain bacteria. In a quote by Jennifer Doudna of the University of California Berkely, one of the leading CRISPR researchers, “This has become such a fast-moving field that I even have trouble keeping up now. We’re getting to the point where the efficiencies of gene editing are at levels that are clearly going to be useful therapeutically, as well as for a vast number of other applications.”